Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 01, 2020 | Chief Financial Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 6,872 | -- | 28,128 | |
| Jul 01, 2020 | Director | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,500 | $15.20 | 30,967 | |
| Jul 02, 2020 | Principal Accounting Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 198 | $10.04 | 1,733 | |
| Jul 02, 2020 | Principal Accounting Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 198 | $15.80 | 17,135 | |
| Jul 02, 2020 | Principal Accounting Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 198 | -- | 5,940 | |
| Jul 06, 2020 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| Jul 07, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 51,531 | $8.61 | 214,735 | |
| Jul 07, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 64,601 | $9.03 | 279,336 | |
| Jul 07, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 12,804 | $10.04 | 292,140 | |
| Jul 07, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 50,052 | $12.28 | 342,192 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.